Esperion Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.2M | 1.1M | 2.99 |
| 2023-09-30 | $1.2M | 1.2M | 0.98 |
| 2023-06-30 | $1.1M | 826k | 1.39 |
| 2023-03-31 | $1.1M | 701k | 1.59 |
| 2022-12-31 | $4.5M | 728k | 6.23 |
| 2022-06-30 | $1.7M | 262k | 6.36 |
| 2022-03-31 | $1.7M | 370k | 4.64 |
| 2021-12-31 | $1.4M | 287k | 5.00 |
| 2021-09-30 | $332k | 28k | 12.05 |
| 2021-03-31 | $497k | 18k | 28.07 |
| 2020-12-31 | $2.6M | 98k | 26.00 |
| 2020-09-30 | $1.7M | 46k | 37.17 |
| 2020-06-30 | $16M | 312k | 51.31 |
| 2019-12-31 | $24M | 406k | 59.63 |
| 2019-09-30 | $11M | 291k | 36.66 |
| 2019-06-30 | $20M | 437k | 46.52 |
| 2019-03-31 | $19M | 465k | 40.15 |
| 2018-12-31 | $15M | 334k | 46.00 |
| 2018-09-30 | $11M | 240k | 44.37 |
| 2018-06-30 | $8.6M | 220k | 39.19 |
| 2018-03-31 | $14M | 188k | 72.33 |
| 2017-12-31 | $22M | 340k | 65.84 |
| 2017-09-30 | $15M | 294k | 50.12 |
| 2017-06-30 | $15M | 320k | 46.28 |
| 2017-03-31 | $4.4M | 124k | 35.31 |
| 2016-12-31 | $881k | 70k | 12.53 |
| 2016-09-30 | $998k | 72k | 13.86 |
| 2016-06-30 | $616k | 62k | 9.87 |
| 2016-03-31 | $2.2M | 129k | 16.92 |
| 2015-12-31 | $3.3M | 146k | 22.27 |
| 2015-09-30 | $3.6M | 153k | 23.60 |
| 2015-06-30 | $57M | 699k | 81.74 |
| 2015-03-31 | $1.6M | 18k | 92.60 |
| 2014-12-31 | $230k | 5.7k | 40.52 |
| 2013-12-31 | $162k | 12k | 13.71 |
| 2013-09-30 | $316k | 17k | 18.86 |